We are proud to continue our city's rich history in world-leading engineering, innovation and creativity. We carry out ground-breaking research. We work closely with our governmental and industrial ...

I've been writing about computers, the internet, and technology professionally for over 30 years, more than half of that time with PCMag. I run several special projects including the Readers ...

In a world where sustainable energy, smart home technology, the Internet of Things and even self-driving cars are a reality, studying Electrical and Electronic Engineering offers students immeasurable ...

CSPC Pharmaceutical Group (CSPC) is a pharmaceutical company, which provides innovative, generic and bulk drugs. The company manufactures, research and markets medicines and pharmaceutical related ...

CSPC Pharmaceutical Group (CSPC) is a pharmaceutical company, which provides innovative, generic and bulk drugs. The company manufactures, research and markets medicines and pharmaceutical related ...

Overview: CSPC Pharmaceutical Group Limited is an investment holding company involved in the research, development, manufacture, and sale of pharmaceutical products across China and ...

Union Budget: The COVID-19 pandemic's impact on global supply chains has driven companies to diversify from China, presenting an opportunity for India to become a major electronics hub. Budget 2025 ...

China National Offshore Oil Corporation (CNOOC) and Shell plc's joint venture, CNOOC and Shell Petrochemicals Company Limited (CSPC), announced Wednesday they would invest in the Huizhou Phase III ...

Maryland’s Board of Public Works has also approved MDTA’s award of a $75-million general engineering consulting contract for the rebuild to Bridging Maryland Partnership, a joint venture of ...

Carolina Foods’ Pineville, N.C. facility has won FOOD ENGINEERING magazine’s Plant of the Year for 2025. The state-of-the-art headquarters and production facility is part of a strategic growth plan ...

CSPC Pharmaceutical Group has announced that its new product, SYS6041, an antibody-drug conjugate, has received clinical trial approval from China’s National Medical Products Administration.